Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-17-037389
Filing Date
2017-02-10
Accepted
2017-02-10 10:26:57
Documents
1
Group Members
MEDIMMUNE VENTURES, INC.

Document Format Files

Seq Description Document Type Size
1 SC 13G d348315dsc13g.htm SC 13G 69743
  Complete submission text file 0001193125-17-037389.txt   71452
Mailing Address 2 KINGDOM STREET - LEGAL DEPARTMENT LONDON X0 W2 6BD
Business Address 2 KINGDOM STREET - LEGAL DEPARTMENT LONDON X0 W2 6BD 011 44 20 7304 5000
ASTRAZENECA PLC (Filed by) CIK: 0000901832 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Subject) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88910 | Film No.: 17590372
SIC: 2834 Pharmaceutical Preparations